Latest Albert David stock price
Albert David P/E Ratio
ALBERTDAVD • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
40.35
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
40.35
Current Price
₹690.80
EPS (TTM)
₹30.14
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.4
Sector Median
25.87
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Albert David
- Stock appears overvalued with PE of 40.35, suggesting caution for new investments
- Trading at discount to sector average PE of 49.4
View the ALBERTDAVD equity price for detailed stock performance.
Related Pages for Albert David
Additional stock information and data for ALBERTDAVD
Sector P/E Ratio Comparison
Comparing Albert David with other companies in Healthcare sector
Sector Average
49.4
Sector Median
25.87
Lowest P/E
0.97
Highest P/E
993.26
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.67 | ₹1,166 | Low |
| Medicamen Organics | MEDIORG | 6.33 | ₹26 | Low |
| Amwill Health Care | AMWILL | 6.53 | ₹70 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |